Biomarker Release After Percutaneous Coronary Intervention
- 1 August 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Cardiovascular Interventions
- Vol. 1 (1), 3-6
- https://doi.org/10.1161/circinterventions.108.799858
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Prevalence and Prognostic Significance of Preprocedural Cardiac Troponin Elevation Among Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary InterventionCirculation, 2008
- What Do You Need to Know Before Performing a Percutaneous Coronary Intervention?Circulation, 2008
- Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2008
- Microvascular Obstruction and the No-Reflow Phenomenon After Percutaneous Coronary InterventionCirculation, 2008
- 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial InfarctionCirculation, 2008
- Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial InfarctionEuropean Heart Journal, 2007
- National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary SyndromesCirculation, 2007
- Baseline troponin level: key to understanding the importance of post-PCI troponin elevationsEuropean Heart Journal, 2006
- Peri-procedural myocardial injury: 2005 updateEuropean Heart Journal, 2005
- Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial InjuryCirculation, 2005